AcouSort approved for listing on Nasdaq First North Growth Market
AcouSort has on November 27, 2020, received approval for admission to trading on the Nasdaq First North Growth Market. The first day of trading on the Nasdaq First North Growth
Read MoreInterim Report Q3 2020
RegulatoryAcouSort publishes its interim report for the third quarter 2020. AcouSort 2020 Q3
Read MoreAcouSort gets two patent applications published
AcouSort has had two new patent applications published. The patents relate to improved methods for manipulating and separating specific cells, for example cancer cells in blood samples. Read the full
Read MoreAcouSort applies for listing on Nasdaq First North Growth Market
AcouSort has today applied to change trading venue to Nasdaq First North Growth Market. The company is currently listed on the Spotlight Stock Market, where the Company’s shares have been
Read MoreAcouSort receives order for AcouTrap from the University of Kentucky
AcouSort has received an order for an AcouTrap system from the University of Kentucky. The order is a direct effect of the evaluation of the system that the university launched
Read MoreAcouSort launches new project with Instrumentation Laboratory
RegulatorySince 2015, AcouSort has worked with Instrumentation Laboratory (IL) on the integration of its technology in IL’s clinical analysis system. The new project aims to investigate whether AcouSort’s technology can
Read MoreAcouSort deltar på Investerarjakten
AcouSort kommer att delta i det livesända eventet Investerarjakten den 14 oktober. Bolagets vd Torsten Freltoft kommer att presentera utvecklingen under det gångna året samt planerna framåt. Presentationen inleds kl
Read MoreAcouSort initiates work on the Blue4Therapy project: The first step towards the stem cell treatment of the future
AcouSort has officially initiated the Blue4Therapy project. The aim of the project is to develop a platform for purification of patients’ own stem cells for further use in clinical applications
Read MoreAcouSort participates in a new important CAMP project
AcouSort will participate in yet another CAMP project. The goal is to develop a GMP-approved production of stem cells. Among other participants in the project are the Region Örebro län,
Read MoreInterim report Q2 2020
RegulatoryOn August 26, AcouSort released its interim report for the second quarter of 2020. The report can be found in Swedish and English here: AcouSort Interim report Q2 2020. For all
Read More